OBJECTIVE: To learn how to configure a patient communication aid (PCA) to facilitate shared decision-making (SDM) about treatment for advanced cancer. METHODS: The PCA consists of education about SDM, a question prompt list, and values clarification methods. Study 1. A first version was presented to 13 patients, 8 relatives and 14 bereaved relatives in interviews. Study 2. A second version was used by 18 patients in a pilot study. Patients and oncologists were interviewed, patients were surveyed, and consultations were audio-recorded. RESULTS: Respondents reported that the aid facilitated patient control over information, raised choice awareness and promoted elaboration. Risks were identified, most importantly that the aid might upset patie...
Background: Systemic treatment for advanced cancer offers uncertain and sometimes little benefit whi...
BACKGROUND: There is a continuing debate on the desirability of informing patients with cancer and t...
Patients with advanced, non-curable cancer face difficult decisions on further treatment, where a sm...
Objective: To learn how to configure a patient communication aid (PCA) to facilitate shared decision...
Background: Palliative systematic treatment offers uncertain and often limited benefits, and the bur...
BACKGROUND: Palliative systematic treatment offers uncertain and often limited benefits, and the bur...
BACKGROUND: Palliative systematic treatment offers uncertain and often limited benefits, and the bur...
Objective: To contribute to the evolving dialogue on optimizing cancer care communication through sy...
Newly diagnosed cancer patients often face multiple treatment options (such as chemotherapy, surgery...
Newly diagnosed cancer patients often face multiple treatment options (such as chemotherapy, surgery...
Newly diagnosed cancer patients often face multiple treatment options (such as chemotherapy, surgery...
A survey (via SurveyMonkey) was sent to lung cancer patients, their caregivers or significant others...
Communication about palliative treatment options requires a balance between providing patients with ...
Shared decision making (SDM) and patient-centered care require patients to actively participate in t...
Abstract Background Systemic treatment for advanced cancer offers uncertain and sometimes little ben...
Background: Systemic treatment for advanced cancer offers uncertain and sometimes little benefit whi...
BACKGROUND: There is a continuing debate on the desirability of informing patients with cancer and t...
Patients with advanced, non-curable cancer face difficult decisions on further treatment, where a sm...
Objective: To learn how to configure a patient communication aid (PCA) to facilitate shared decision...
Background: Palliative systematic treatment offers uncertain and often limited benefits, and the bur...
BACKGROUND: Palliative systematic treatment offers uncertain and often limited benefits, and the bur...
BACKGROUND: Palliative systematic treatment offers uncertain and often limited benefits, and the bur...
Objective: To contribute to the evolving dialogue on optimizing cancer care communication through sy...
Newly diagnosed cancer patients often face multiple treatment options (such as chemotherapy, surgery...
Newly diagnosed cancer patients often face multiple treatment options (such as chemotherapy, surgery...
Newly diagnosed cancer patients often face multiple treatment options (such as chemotherapy, surgery...
A survey (via SurveyMonkey) was sent to lung cancer patients, their caregivers or significant others...
Communication about palliative treatment options requires a balance between providing patients with ...
Shared decision making (SDM) and patient-centered care require patients to actively participate in t...
Abstract Background Systemic treatment for advanced cancer offers uncertain and sometimes little ben...
Background: Systemic treatment for advanced cancer offers uncertain and sometimes little benefit whi...
BACKGROUND: There is a continuing debate on the desirability of informing patients with cancer and t...
Patients with advanced, non-curable cancer face difficult decisions on further treatment, where a sm...